Jean Beissel

Author PubWeight™ 10.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006 1.75
2 First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). BMC Public Health 2010 1.50
3 Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc 2002 1.08
4 Level of unawareness and management of diabetes, hypertension, and dyslipidemia among adults in Luxembourg: findings from ORISCAV-LUX study. PLoS One 2013 0.95
5 Is strength training the more efficient training modality in chronic heart failure? Med Sci Sports Exerc 2007 0.94
6 Social inequality in awareness of cardiovascular risk factors in patients undergoing coronary angiography. Eur J Prev Cardiol 2012 0.88
7 Cardiovascular health: a cross-national comparison between the Maine Syracuse Study (Central New York, USA) and ORISCAV-LUX (Luxembourg). BMC Public Health 2014 0.82
8 Acculturation, immigration status and cardiovascular risk factors among Portuguese immigrants to Luxembourg: findings from ORISCAV-LUX study. BMC Public Health 2012 0.80
9 Reverse remodelling through exercise training is more pronounced in non-ischemic heart failure. Clin Res Cardiol 2008 0.78
10 Percutaneous coronary interventions in Europe 1992-2003. EuroIntervention 2006 0.77
11 Cell therapy for severe chronic heart failure: the Luxembourg experience. Biomed Mater Eng 2008 0.77
12 Right coronary artery originating in the left ventricle. J Am Coll Cardiol 2010 0.76
13 Relationship between pulse transit time and blood pressure is impaired in patients with chronic heart failure. Clin Res Cardiol 2010 0.75
14 Improvement of exercise-induced cardiac deformation after cell therapy for severe chronic ischemic heart failure. J Card Fail 2006 0.75
15 [Lucky National Registry (Luxembourg Acute Myocardial Infarction Registry). Are women much better taken care of than men?]. Bull Soc Sci Med Grand Duche Luxemb 2008 0.75